Skip to main content
Clinical Trials/IRCT2017050833875N1
IRCT2017050833875N1
Completed
Phase 3

Effect of intravitreal injection of Bevacizumab and subtenon injection of Triamcinolone and topical diclofenac eye drop in preventing the incidence of diabetic macular edema after phaco with intraocular lens implementing

Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences0 sites45 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Diabetic retinopathy.
Sponsor
Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences
Enrollment
45
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria: Diabetic patients with cataract and without diabetic macular edema; Nonproliferation diabetic retinopathy.

Exclusion Criteria

  • Glaucoma; Eye trauma; Laser therapy 12 months prior to cataract surgery; Any history of eye surgery 6 months ago.

Outcomes

Primary Outcomes

Not specified

Similar Trials